Previous studies, including ours, have reported that AHR ligands, including coal tar, soybean tar, and 6-formylindolo[3,2-b]carbazole (FICZ), could improve skin barrier dysfunction in AD [7,8,9,10], suggesting that an AHR ligand could become a therapeutic agent for treating AD. The gene discussed is AHR; the disease is Alzheimer disease.